<SEC-DOCUMENT>0001193125-19-266639.txt : 20191125
<SEC-HEADER>0001193125-19-266639.hdr.sgml : 20191125
<ACCEPTANCE-DATETIME>20191011143209
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-19-266639
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20191011

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Solid Biosciences Inc.
		CENTRAL INDEX KEY:			0001707502
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				900943402
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		141 PORTLAND STREET, FIFTH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-337-4680

	MAIL ADDRESS:	
		STREET 1:		141 PORTLAND STREET, FIFTH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Solid Biosciences, LLC
		DATE OF NAME CHANGE:	20170524
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g773972g1011075018193.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;11, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>By
Electronic Submission </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100 F Street, N.E. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, D.C. 20549 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Sonia Bednarowski </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Solid Biosciences Inc. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Filed September&nbsp;3, 2019 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>File <FONT STYLE="white-space:nowrap">No.&nbsp;333-233594</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Solid Biosciences Inc. (the
&#147;Company&#148;), we are responding to the comment of the staff (the &#147;Staff&#148;) of the Securities and Exchange Commission (the &#147;Commission&#148;) contained in its letter dated September&nbsp;4, 2019 (the &#147;Comment Letter&#148;),
relating to the above referenced Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> filed on September&nbsp;3, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth
below is the Company&#146;s response to the Staff&#146;s comment. The response set forth below is based upon information provided to Wilmer Cutler Pickering Hale and Dorr LLP by the Company. For convenience, the response is keyed to the numbering of
the comment and the heading used in the Comment Letter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>General </U></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>We note that the forum selection provisions in your certificate of incorporation and bylaws identify the
Court of Chancery of the State of Delaware as the exclusive forum for certain litigation, including any &#147;derivative action.&#148; Please disclose whether these provisions apply to actions arising under the Securities Act or Exchange Act. In
that regard, we note that Section</I><I></I><I>&nbsp;27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder, and
Section</I><I></I><I>&nbsp;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. If the
provisions apply to Securities Act claims, please also revise your prospectus to state that there is uncertainty as to whether a court would enforce such provision and that investors cannot waive compliance with the federal securities laws and the
rules and regulations thereunder. If this provision does not apply to actions arising under the Securities Act or Exchange Act, please tell us how you will inform investors in future filings that the provision does not apply to any actions arising
under the Securities Act or Exchange Act.</I> </P></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;11, 2019 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Response:</B> The choice of forum
provision will not apply to actions arising under the Securities Act or the Exchange Act. Therefore, in the Company&#146;s future quarterly and annual reports, including the Company&#146;s Quarterly Report on Form
<FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended September&nbsp;30, 2019, the Company will revise its existing risk factor disclosure on this topic as follows (with revisions emphasized below by italicized and underlined text):
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Our certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for
certain litigation that may be initiated by our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for such disputes with us or our directors, officers or employees.</I></B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation provides that<I><U>, unless we consent in writing to the selection of an alternative forum,</U></I> the Court
of Chancery of the State of Delaware is the exclusive forum for (i)&nbsp;any derivative action or proceeding brought on our behalf, (ii)&nbsp;any action asserting a claim for breach of a fiduciary duty owed by any of our directors, officers or other
employees to us or our stockholders, (iii)&nbsp;any action asserting a claim arising pursuant to any provision of the DGCL, our certificate of incorporation or our bylaws or (iv)&nbsp;any action asserting a claim governed by the internal affairs
doctrine. <I><U>We do not intend to have this choice of forum provision apply to, and this choice of forum provision will not apply to, actions arising under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as
amended.</U></I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The choice of forum provision may limit a stockholder&#146;s ability to bring a claim in a judicial forum that it finds
favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. Alternatively, if a court were to find the choice of forum provision
contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you have any further questions or comments, or if you require any additional information, please contact the undersigned by telephone at (617) <FONT
STYLE="white-space:nowrap">526-6982</FONT> or <FONT STYLE="white-space:nowrap">e-mail</FONT> at lia.dermarderosian@wilmerhale.com. Thank you for your assistance. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lia Der Marderosian</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lia Der Marderosian</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ilan Ganot, <I>Solid Biosciences Inc.</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Lynette Herscha, <I>Solid Biosciences Inc.</I> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g773972g1011075018193.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g773972g1011075018193.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  0 'P# 2(  A$! Q$!_\0
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MJ49/G8\@]..:Y;0-2N-/TWQO!;)<P7^H:W.;*1X)%4+,P19MVTC:O+GV7W%
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+C.-WY$#.0: /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
